Found 16 results
Author Title [ Type(Desc)] Year
Filters: Author is Anzala, O  [Clear All Filters]
Conference Paper
P. Hayes, Fernandez, N., Omosa-Manyonyi, G., Mpendo, J., Karita, E., Ruzagira, E., Kilembe, W., Mutua, G., Anzala, O., Roman, F., Bourguignon, P., Barin, B., Eldridge, J., Egan, M., Hannaman, D., Schmidt, C., Fast, P., Priddy, F., Cox, J., and Gilmour, J., Assessment of Viral Inhibition Activity in Low Seroprevalent Adenovirus-35 Vectored HIV Vaccines +/- Adjuvanted Protein or Electroporated DNA, in HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P), Cape Town, SA, 2014.
J. Cox, Farah, B., Langat, R., Indangasi, J., Ogola, S., Onsembe, B., Kopycinski, J., Hayes, P., Borthwick, N., Barin, B., Gilmour, J., De Bont, J., Anzala, O., Fast, P., Reilly, M., Chinyenze, K., Mutua, G., Jaoko, W., and Hanke, T., Broad HIV-1 Inhibition in Vitro by Vaccine-Elicited CD8+ T Cells in African Adults, in HIV R4P 2016, Chicago, IL, 2016.
H. Ogutu, Wakasiaka, S., Malogo, R., Ndambuki, R., Nyange, J., Omosa, G., Anzala, O., Bwayo, J., Fast, P., Schmidt, C., Verlinde, C., Smith, C., Ndinya-Achola, J., and Jaoko, W., Challenges of Use and Compliance With Effective Contraceptives Among Female Participants in Preventive HIV Vaccine Trials: The Kenyan Experience, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
E. Karita, Anzala, O., Gazzard, B., Bergin, P., Nyombayire, J., Omosa, G., ,, Dally, L., Barin, B., Inoue, M., Hara, H., Hironaka, T., Shu, T., Hasegawa, M., Matano, T., Sayeed, E., Parks, C., Ackland, J., Fast, P., Gilmour, J., Cox, J., Lombardo, A., and Laufer, D., Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G(NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers, in HIVR4P (HIV Research for Prevention), Cape Town, South Africa, 2014.
A. Kamali, Karita, E., Kayitenkore, K., Kaleebu, P., Nanvubya, A., Anzala, O., Jaoko, W., Mutua, G., Ruzagira, E., Mulenga, J., Sanders, E., Mwangome, M., Allen, S., Amornkul, P., Price, M., Stevens, G., Dally, L., Excler, J., and , A Cross-Sectional Study in Eastern and Southern Africa to Characterize Laboratory Reference Intervals in Healthy Adults for HIV Prevention Trials, in AIDS Vaccine 2008 Conference, Cape Town, South Africa, 2008.
B. Peters, Jaoko, W., Anzala, O., Judges, L., G Manyonyi, O., Sharp, A., Gray, K., Fast, P., Schmidt, C., Gilmour, J., Smith, C., Dally, L., Loughran, K., Farah, B., Tarragona, T., Hayes, P., McMichael, A., Hanke, T., and Bwayo, J., Phase 2A Dose and Route Study of a DNA Prime MVA Boost Vaccine Candidate, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
J. Nyombayire, Anzala, O., Gazzard, B., Karita, E., Bergin, P., Hayes, P., Kopycinski, J. T., Omosa, G., Jackson, A., Bizimana, J., Farah, B., Sayeed, E., Parks, C., Inoue, M., Gilmour, J., Lombardo, A., Fast, P. E., Laufer, D., and Cox, J. H., Recombinant Sendai Vaccine Delivered Mucosally Induces Potent Gag-Specific T-Cell or Antibody Responses Depending on Prime Boost Regimen in Humans, in HIV R4P 2016, Chicago, IL, 2016.
Journal Article
G. Omosa-Manyonyi, Park, H., Mutua, G., Farah, B., Bergin, P. J., Laufer, D., Lehrman, J., Chinyenze, K., Barin, B., Fast, P., Gilmour, J., and Anzala, O., Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya, PLoS One, vol. 9, p. e110228, 2014.
W. Stevens, Kamali, A., Karita, E., Anzala, O., Sanders, E. J., Jaoko, W., Kaleebu, P., Mulenga, J., Dally, L., Fast, P., Gilmour, J., Farah, B., Birungi, J., Hughes, P., Manigart, O., Stevens, G., Yates, S., Thomson, H., ,, Stoll-Johnson, L., and Ketter, N., Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials, PLoS ONE, vol. 3, p. e2043, 2008.
G. Mutua, Farah, B., Langat, R., Indangasi, J., Ogola, S., Onsembe, B., Kopycinski, J. T., Hayes, P., Borthwick, N. J., Ashraf, A., Dally, L., Barin, B., Tillander, A., Gilmour, J., De Bont, J., Crook, A., Hannaman, D., Cox, J. H., Anzala, O., Fast, P. E., Reilly, M., Chinyenze, K., Jaoko, W., and Hanke, T., Broad HIV-1 Inhibition in Vitro by Vaccine-Elicited CD8(+) T Cells in African Adults, Mol Ther Methods Clin Dev, vol. 3, no. 16061, p. 16061, 2016.
E. Karita, Ketter, N., Price, M., Kayitenkore, K., Kaleebu, P., Nanvubya, A., Anzala, O., Jaoko, W., Mutua, G., Ruzagira, E., Mulenga, J., Sanders, E., Mwangome, M., Allen, S., Bwanika, A., Bahemuka, U., Awuondo, K., Omosa, G., Farah, B., Amornkul, P., Birungi, J., Yates, S., Stoll-Johnson, L., Gilmour, J., Stevens, G., Shutes, E., Manigart, O., Hughes, P., Dally, L., Scott, J., Stevens, W., Fast, P., and Kamali, S., CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa, PLoS ONE, vol. 4, no. 2, p. e4401, 2009.
B. M. Farah, Ogola, S., Anzala, O., Indangasi, J., Tarragona, A., Gibiansky, L., and Bwayo, J., Development and validation of gamma interferon ELISPOT assay for HIV-1 vaccine trials in Kenya, 2004.
G. Mutua, Sanders, E., Mugo, P., Anzala, O., Haberer, J. E., Bangsberg, D., Barin, B., Rooney, J. F., Mark, D., Chetty, P., Fast, P., and Priddy, F. H., Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers, PLoS One, vol. 7, p. e33103, 2012.
W. Jaoko, Karita, E., Kayitenkore, K., Omosa-Manyonyi, G., Allen, S., Than, S., Adams, E., Graham, B., Koup, R., Bailer, R., Smith, C., Dally, L., Farah, B., Anzala, O., Muvunyi, C., Bizimana, J., Tarragona-Fiol, T., Bergin, P., Hayes, P., Ho, M., Loughran, K., and Komaroff, W., Safety and Immunogenicity Study of Multiclade HIV-1 Adeno-Viral Vector Vaccine Alone or as Boost Following a Multiclade HIV-1 DNA Vaccine in Africa, PLoS ONE, vol. 5, p. e12873, 2010.
P. M. Mugo, Sanders, E., Mutua, G., van der Elst, E., Anzala, O., Barin, B., Bangsberg, D., Priddy, F., and Haberer, J. E., Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-Exposure Prophylaxis Among Men Who Have Sex With Men in Kenya, AIDS Behav, vol. 19, pp. 794-801, 2015.
A. Spentzou, Bergin, P., Gill, D., Cheeseman, H., Ashraf, A., Kaltsidis, H., Cashin-Cox, M., Anjarwalla, I., Steele, A., Higgs, C., Pozniak, A., Piechocka-Trocha, A., Wong, J., Anzala, O., Karita, E., Dally, L., Gotch, F., Walker, B., Gilmour, J., and Hayes, P., Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of Human Immunodeficiency Virus-1 Vaccine Candidates, J Infect Dis, vol. 201, pp. 720-729, 2010.